September 2017
  • Mergers & acquisitions

Based in Tours, AXESS VISION TECHNOLOGY (AVT), is specialized in the development, production and marketing of innovative products in the medical equipment field, and in particular, in the high potential segment of disposable endoscopes. Founded in 2006, AVT is supported by four French private equity funds (APICAP, SOFIMAC Partners, CAP DECISIF Management et ACG Management) and a dozen of physical persons including the founders. The company, which offers the first CE-marked single-use video-endoscope since 2013, was seeking to be backed by a major industrial partner to ensure continuity towards a new growth stage and its international deployment.

THE SURGICAL COMPANY (TSC) is a Dutch family Group present in the distribution of medical devices on behalf of third parties on the one hand and of innovative medical devices under its own brands (The 37th Company – Hemologic – Sensium …) on the other hand. Its European influence, and particularly its presence in France, enabled the Group to generate € 120 million in sales during the last financial year.

ATOUT CAPITAL advised TSC for the takeover of AVT, through a capital increase, granting them with 55% of the capital at the signature and allowing them to benefit from options increasing its stakes up to 100%. This operation, which rewards 10 years of R&D efforts, is in line with a true logic of industrial partnership for an innovative company that reached a phase of technological and commercial maturity, which will now have stable resources and ambitious shareholders to reinforce its leadership.

This operation is the achievement for ATOUT CAPITAL of a first cross-border deal initiated with one of its partners from the GLOBALSCOPE M&A network (www.globalscopepartners.com).

Can we help you?
In both public and private companies, Atout Capital is able
to provide a unique transversal expertise with a 360 degree approach.